ENT Support

Active substance: PULSATILLA PRATENSIS WHOLE, EUPHORBIA RESINIFERA RESIN, LUFFA OPERCULATA FRUIT, MERCURIC IODIDE, SILVER NITRATE, CALCIUM SULFIDE, INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED), SINUSITISINUM, ASPERGILLUS NIGER VAR. NIGER, CANDIDA ALBICANS, GALLIC ACID MONOHYDRATE, MUCOR RACEMOSUS, ESCHERICHIA COLI

LIQUID · PULSATILLA PRATENSIS WHOLE 4 [hp_X]/mL, EUPHORBIA RESINIFERA RESIN 6 [hp_X]/mL, LUFFA OPERCULATA FRUIT 6 [hp_X]/mL, MERCURIC IODIDE 8 [hp_X]/mL, SILVER NITRATE 10 [hp_X]/mL, CALCIUM SULFIDE 10 [hp_X]/mL, INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 12 [hp_X]/mL, INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 12 [hp_X]/mL, INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 12 [hp_X]/mL, INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) 12 [hp_X]/mL, SINUSITISINUM 17 [hp_X]/mL, ASPERGILLUS NIGER VAR. NIGER 10 [hp_C]/mL, CANDIDA ALBICANS 10 [hp_C]/mL, GALLIC ACID MONOHYDRATE 10 [hp_C]/mL, MUCOR RACEMOSUS 10 [hp_C]/mL, ESCHERICHIA COLI 30 [hp_C]/mL

United StatesActive

Marketing holder: Deseret Biologicals, Inc.

Verified 2026-10-09 · openFDA NDC

Source: openFDA NDC

Composition

PULSATILLA PRATENSIS WHOLE · 4 [hp_X]/mL
EUPHORBIA RESINIFERA RESIN · 6 [hp_X]/mL
LUFFA OPERCULATA FRUIT · 6 [hp_X]/mL
MERCURIC IODIDE · 8 [hp_X]/mL
SILVER NITRATE · 10 [hp_X]/mL
CALCIUM SULFIDE · 10 [hp_X]/mL
INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) · 12 [hp_X]/mL
INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) · 12 [hp_X]/mL
INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) · 12 [hp_X]/mL
INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) · 12 [hp_X]/mL
SINUSITISINUM · 17 [hp_X]/mL
ASPERGILLUS NIGER VAR. NIGER · 10 [hp_C]/mL
CANDIDA ALBICANS · 10 [hp_C]/mL
GALLIC ACID MONOHYDRATE · 10 [hp_C]/mL
MUCOR RACEMOSUS · 10 [hp_C]/mL
ESCHERICHIA COLI · 30 [hp_C]/mL

Registration

Registration number: 43742-2061
Registration status: Active
Dispensing: Over the counter
Route: ORAL

Sources

product · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
ingredients.5 · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
ingredients.6 · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
ingredients.7 · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
ingredients.8 · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
ingredients.9 · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
ingredients.10 · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
ingredients.11 · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
ingredients.12 · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
ingredients.13 · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
ingredients.14 · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source
ingredients.15 · openFDA NDC · 43742-2061 · Verified 2026-10-09 · open in source